| 000 | 01259 a2200349 4500 | ||
|---|---|---|---|
| 005 | 20250513222106.0 | ||
| 264 | 0 | _c20001107 | |
| 008 | 200011s 0 0 eng d | ||
| 022 | _a0002-9343 | ||
| 024 | 7 |
_a10.1016/s0002-9343(00)00582-9 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSebastian, A | |
| 245 | 0 | 0 |
_aThiazides and bone. _h[electronic resource] |
| 260 |
_bThe American journal of medicine _cOct 2000 |
||
| 300 |
_a429-30 p. _bdigital |
||
| 500 | _aPublication Type: Comment; Editorial | ||
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aCalcium _xmetabolism |
| 650 | 0 | 4 |
_aCalcium, Dietary _xadministration & dosage |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aDiuretics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFractures, Bone _xetiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydrochlorothiazide _xpharmacology |
| 650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xcomplications |
| 650 | 0 | 4 |
_aPotassium _xadministration & dosage |
| 650 | 0 | 4 |
_aSodium Chloride Symporter Inhibitors _xpharmacology |
| 773 | 0 |
_tThe American journal of medicine _gvol. 109 _gno. 5 _gp. 429-30 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9343(00)00582-9 _zAvailable from publisher's website |
| 999 |
_c10966111 _d10966111 |
||